Disclosures for "Catechol-O-Methyltransferase (COMT) Genotypes and Cognitive Resilience in Patients With Primary Brain Tumors"
-
Dr. Bartman has nothing to disclose.
-
Dr. Allen has nothing to disclose.
-
Dr. Affronti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Society for Neuro-Oncology. Dr. Affronti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for of the Multinational Association of Supportive Care in Cancer . The institution of Dr. Affronti has received research support from TerSera.
-
The institution of Dr. Walker has received research support from NIAID.
-
Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.